Literature DB >> 10522610

Low circulating insulin-like growth factor I in coeliac disease and its relation to bone mineral density.

T Valdimarsson1, H J Arnqvist, G Toss, G Järnerot, F Nyström, M Ström.   

Abstract

BACKGROUND: Patients with coeliac disease have low bone mineral density (BMD), but the underlying mechanisms are unclear. Our aim was to study circulating insulin-like growth factor I (IGF-I) and its possible relationship to BMD in adults with untreated coeliac disease and after 1 year on a gluten-free diet.
METHODS: In 29 consecutive adult coeliac patients fasting IGF-I and BMD (n = 28) were examined before and 1 year after starting a gluten-free diet. Intact parathyroid hormone (PTH) was measured (n = 20) before the gluten-free diet was started.
RESULTS: Untreated coeliac patients had lower IGF-I values than controls matched for age and sex, and their BMD was low. A relationship was observed between BMD and IGF-I but not independent of age and body mass index. During the 1st year on a gluten-free diet BMD increased (P < 0.001), as did the circulating IGF-I levels in 21 of the 29 patients (P = 0.078). In the subgroup of 14 patients with normal initial PTH the increase in IGF-I correlated positively with the increase in BMD (femoral trochanter, r = 0.62, P < 0.05, and lumbar spine, r = 0.70, P < 0.02).
CONCLUSIONS: BMD and circulating IGF-I levels are low in adults with untreated coeliac disease. In patients with normal initial PTH level there is an association between the change in BMD and circulating IGF-I, although this parallel increase may not be causally connected.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10522610     DOI: 10.1080/003655299750025381

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Bone-specific antibodies in sera from patients with celiac disease: characterization and implications in osteoporosis.

Authors:  Emilia Sugai; Alejandra Cherñavsky; Silvia Pedreira; Edgardo Smecuol; Horacio Vazquez; Sonia Niveloni; Roberto Mazure; Eduardo Mauriro; Gabriel A Rabinovich; Julio C Bai
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

Review 2.  Evaluation and management of skeletal health in celiac disease: position statement.

Authors:  Mona A Fouda; Aliya A Khan; Muhammad Saad Sultan; Lorena P Rios; Karen McAssey; David Armstrong
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

3.  Elevated liver enzymes, anaemia and osteopaenia in a young woman.

Authors:  Barbara Rubek Nielsen; Peter Schwarz; Steffen Friis; Lise Lotte Gluud
Journal:  BMJ Case Rep       Date:  2012-06-15

Review 4.  Celiac disease: an underappreciated issue in women&#x2019;s health.

Authors:  Sveta Shah; Daniel Leffler
Journal:  Womens Health (Lond)       Date:  2010-09

Review 5.  Bone in celiac disease.

Authors:  M-L Bianchi; M T Bardella
Journal:  Osteoporos Int       Date:  2008-04-17       Impact factor: 4.507

Review 6.  Insulin-Like Growth Factor-I is a Marker for the Nutritional State.

Authors:  Colin P Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2015-12

7.  Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota.

Authors:  Mohammed R Jafri; Charles W Nordstrom; Joseph A Murray; Carol T Van Dyke; Ross A Dierkhising; Alan R Zinsmeister; Lee J Melton
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

Review 8.  Bones of contention: bone mineral density recovery in celiac disease--a systematic review.

Authors:  Patricia Grace-Farfaglia
Journal:  Nutrients       Date:  2015-05-07       Impact factor: 5.717

Review 9.  Bone mass and mineral metabolism alterations in adult celiac disease: pathophysiology and clinical approach.

Authors:  Michele Di Stefano; Caterina Mengoli; Manuela Bergonzi; Gino Roberto Corazza
Journal:  Nutrients       Date:  2013-11-22       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.